Clinical Data Management From Wiley

Product Description

Extensively revised and updated, with the addition of new chapters and authors, this long-awaited second edition covers all aspects of clinical data management. Giving details of the efficient clinical data management procedures required to satisfy both corporate objectives and quality audits by regulatory authorities, this text is timely and an important contribution to the literature.

The volume:

* is written by well-known and experienced authors in this area

* provides new approaches to major topics in clinical data management

* contains new chapters on systems software validation, database design and performance measures.

It will be invaluable to anyone in the field within the pharmaceutical industry, and to all biomedical professionals working in clinical research.
Product Details

* Amazon Sales Rank: #746453 in Books
* Published on: 2000-04-14
* Number of items: 1
* Binding: Hardcover
* 354 pages

Editorial Reviews

Review
"The key to enduring research is data quality and data quality depends upon data management. How fortunate then that the start of the New Millennium sees the publication of the second edition of 'Clinical Data Management'. ... Admirably concise and authoritatively penned, it provides an excellent introduction to a subject at the heart of pharmaceutical R&D.", Dr Hugh Boardman, Partner in Boardman Clarke, Pharmaceutical Physician#

Book Info
Univ. of Surrey, UK. Covers all aspects of the subject and contains new chapters on systems software validation, database design, and performance measures. For those in the field of clinical data management with the pharmaceutical industry, or biomedical professionals in clinical research. Previous edition: c1993. DNLM: Information Systems.

The publisher, John Wiley & Sons
Multinational contributors renowned for their extensive industry experience offer concise, well-researched information on all aspects of data management. Coverage ranges from handling early phase I studies in volunteers to the presentation of final reports for regulatory purposes. Uses an international approach to describe such specialized needs as clinical trial monitoring, the audit process and regulatory requirements.